ETI Karle Clinical, based in India, will conduct Oramed Pharmaceuticals Phase IIb trials on its oral insulin capsules in diabetic type 2 patients.

It is anticipated that the Phase IIb study will enroll 60 subjects and begin in the first quarter of 2009.